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Mitochondria are highly specialised organelles required for key cellular processes including
ATP production through cellular respiration and controlling cell death via apoptosis. Unlike
other organelles, mitochondria contain their own DNA genome which encodes both protein
and RNA required for cellular respiration. Each cell may contain hundreds to thousands of
copies of the mitochondrial genome, which is essential for normal cellular function – devia-
tion of mitochondrial DNA (mtDNA) copy number is associated with cellular ageing and dis-
ease. Furthermore, mtDNA lesions can arise from both endogenous or exogenous sources
and must either be tolerated or corrected to preserve mitochondrial function. Importantly,
replication of damaged mtDNA can lead to stalling and introduction of mutations or genetic
loss, mitochondria have adapted mechanisms to repair damaged DNA. These mechanisms
rely on nuclear-encoded DNA repair proteins that are translocated into the mitochondria.
Despite the presence of many known nuclear DNA repair proteins being found in the mi-
tochondrial proteome, it remains to be established which DNA repair mechanisms are
functional in mammalian mitochondria. Here, we summarise the existing and emerging
research, alongside examining proteomic evidence, demonstrating that mtDNA damage
can be repaired using Base Excision Repair (BER), Homologous Recombination (HR) and
Microhomology-mediated End Joining (MMEJ). Critically, these repair mechanisms do not
operate in isolation and evidence for interplay between pathways and repair associated with
replication is discussed. Importantly, characterising non-canonical functions of key proteins
and understanding the bespoke pathways used to tolerate, repair or bypass DNA damage
will be fundamental in fully understanding the causes of mitochondrial genome mutations
and mitochondrial dysfunction.
Introduction
Mitochondria are highly specialised and dynamic organelles required for fundamental cellular pro-
cesses including ATP generation via oxidative phosphorylation during cellular respiration and the con-
trol of programmed cell death by apoptosis (reviewed in [1]). Unlike other mammalian organelles,
mitochondria contain their own 16.5 kb circular DNA genome (often referred to as mitochondrial
DNA or mtDNA) comprising 37 genes which in turn encode 13 peptides required for the respira-
tory chain complexes (I–IV) and ATP synthase [2]. A further 22 transfer RNAs and 2 ribosomal
RNAs enable protein synthesis of these proteins within the mitochondria [3]. Compartmentalised in
the mitochondrial matrix, each cell is estimated to contain hundreds to thousands of copies of the
mitochondrial genome dependent on the cell type and between eight and ten copies per mitochon-
drion [3]. This genetic material is clustered and organised into distinct nucleoid structures marked
predominantly by association with mitochondrial transcription factor A (TFAM) and several other
mtDNA-associated proteins [4,5]. Mitochondrial nucleoids are associated with the inner mitochon-
drial membrane and support mtDNA packaging, replication and mediate signalling (reviewed in [6])
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Critically, mtDNA loss or a decrease in the number of functional copies of the mitochondrial genome has been
shown to cause multiple human pathologies including a group of heritable syndromes referred to as mitochondrial
DNA depletion syndromes (MDDSs) which are often characterised by neurological features, hypotonia and gastroin-
testinal problems identifiable in infancy [7]. These syndromes and the underlying mechanism of disease, arise from
defects not within the mitochondrial genome, but within nuclear genes that function to protect the genetic integrity
of the mtDNA [8].
One of the best studied examples of nuclear-encoded proteins maintaining the integrity of the mitochondrial
genome is polymerase γ (POLγ) which was originally thought to be the sole polymerase responsible for replication
of the mitochondrial genome [9]. Mutations in the nuclear genes encoding subunits of POLγ, POLG and POLG2,
that affect the proofreading capability of the polymerase have been shown to elevate misincorporation of bases and
mutagenesis in the mitochondrial genome and accelerate cellular ageing [10–12]. As a result, cataloging variations
in the POLG gene are of particular interest in tracking increased genomic instability of the mitochondrial genome
and associated diseases (reviewed by [13]). In addition, altered mitochondrial genome copy number has also been
observed in human cancers as demonstrated by analysing data from The Cancer Genome Atlas [14]. Though it re-
mains to be established whether this contributes to the disease phenotype or occurs because of the abnormal cellular
physiology. In either case, mitochondrial genome copy number and integrity of mtDNA must be carefully maintained
to protect mitochondrial function.
Despite the approximately ten-fold elevated rate of mutation, mitochondrial function is arguably more resilient to
individual genetic changes in single copies of the mitochondrial genome such as single-nucleotide polymorphisms
(SNPs) and mutations due to the large copy number [15]. Unlike the diploid nuclear genome with only two copies of
each gene, base changes in a small proportion of the total number of copies of the mitochondrial genome are unlikely
to yield a negative impact or lead to disease due to the presence of hundreds to thousands of additional copies capable
of compensating for the genetic change [3]. The presence of both normal and abnormal copies of the mitochondrial
genome within a single cell is referred to as heteroplasmy and is estimated to only affect 1–2% of the total copy
number [16]. In contrast, homoplasmy describes when all copies of the mitochondrial genome within a eukaryotic
cell are identical, this term can be applied to both uniformly normal and abnormal mtDNA sequences assuming they
are the sole variant present [16]. Critically, mitochondrial heteroplasmy has been linked to diseases such as cancer
and can play a role in other conditions through the ‘threshold’ effect [17]. In the threshold model, heteroplasmy may
not lead to disease phenotypes unless the ratio of normal to abnormal mtDNA shifts across a threshold at which
point the disease phenotype becomes apparent [16,18]. The role of heteroplasmy in disease, however, is likely more
complex with variable levels of heteroplasmy having been identified in different human tissues alongside associations
with cellular ageing, neurodegenerative diseases and cancers [19–21]. Mechanistically, the proteins that govern and
maintain integrity of the mitochondrial genome either through DNA replication or repair are of particular interest
for understanding the aetiology of mitochondrial dysfunction and disease.
Mitochondrial localisation of nuclear-encoded DNA repair
genes
Characterising the impact of proteins, encoded by nuclear genes, on mitochondrial function and protection of
mtDNA is largely challenging as many of these genes do not appear to contain a clear consensus mitochondrial
localisation signal peptide [22]. Many proteins are found in multiple cellular compartments, which in the case of
mitochondria often involves a mitochondrial localisation signal encoded within the peptide sequence of the protein,
such as alternative splicing of the DNA glycosylase, 8-Oxoguanine DNA Glycosylase (OGG1) [23,24]. Alternative
splicing as well as alternative transcript and translation start sites also give rise to multiple transcript variants which
can dictate the localisation of a protein via the inclusion/exclusion of mitochondrial localisation signals respectively
[24]. Other characterised examples include DNA ligase III, which functions in both nuclear and mitochondrial com-
partments and contains an upstream, in-frame start codon that leads to the inclusion of a mitochondrial targeting
peptide when used to initiate translation [25]. In contrast, alternative splicing and use of alternative transcription ini-
tiation sites of the UNG gene, encoding the uracil DNA glycosylase, permits the inclusion of the targeting sequence
[26,27]. However, many more proteins that are targeted to the mitochondria have yet to have a defined consensus
targeting sequence attributed to them or may be trafficked with other proteins containing localisation signals.
The Integrated Mitochondrial Protein Index (IMPI-2021-Q3pre) has proved to be a powerful resource for probing
the mitochondrial proteome – the current iteration of the curated list comprises over 1300 mitochondrially localised
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proteins [28]. This dataset provides an invaluable snapshot of all the genes with protein products in which strong evi-
dence for mitochondrial localisation has been collated. In the nuclear genome, 584 genes have been annotated with the
‘DNA repair’ Gene Ontology annotation (GO:0006281) [29]. A list of mitochondrially localised DNA repair proteins
can be generated by searching for protein products of the DNA repair gene candidates against IMPI (Figure 1A). This
approach identifies 40 candidates from the current iteration of IMPI and gene ontologies (full list in Supplementary
Table S1). Unsurprisingly, many proteins required for BER are among these candidates including the glycosylases,
OGG1, MutY DNA Glycosylase (MUTYH), N-Methylpurine DNA Glycosylase (MPG) and Uracil-DNA Glycosylase
(UNG) as well as the flap endonuclease, FEN1 [30,31]. However, many more candidates known to function in other
DNA repair pathways are also present such as RAD51 recombinase and the two RAD51 paralogue proteins, RAD51C
and XRCC3 [32]. Gene ontology enrichment analysis using the R package, clusterProfileR, reveals that in addition
to BER, double-strand break (DSB) repair and DNA recombination gene ontologies are also significantly enriched
among the list of candidates (Figure 1B) [33]. Despite this, the mechanistic role of many of these proteins and the
DNA repair pathways that can operate within mammalian mitochondria remain unclear. However, depletion or dele-
tion of a number of these proteins does have an impact on mitochondrial genome stability and integrity [34–36]. It is
interesting to note that the individual biological processes identified do not necessarily contain the full complement of
machinery classically required to process canonical lesions. Potentially, they may use a combination of various path-
ways or the involvement of non-canonical roles of these proteins that illustrates their importance in mitochondrial
genome maintenance. In the following sections, evidence for an expanded repertoire of mtDNA repair pathways is
discussed alongside potential interplay between mtDNA repair and replication based on emerging evidence as well
as insights from the nuclear genome (overview provided in Figure 2A,B).
BER in maintenance of genetic integrity
Notwithstanding the overwhelming importance of maintaining the genomic stability of the mitochondrial genome,
the mechanisms that protect and repair mtDNA remain largely understudied. For many years, mitochondria were
thought to be devoid of the mechanisms necessary to repair DNA lesions supported by the persistence of mtDNA
damage beyond that of the nuclear genome [37,38]. Elevated oxidative mtDNA damage likely results from cellular
respiration and the generation of reactive oxygen species (ROS) which in turn can modify DNA bases [37]. However,
research has shown that mitochondria can repair certain types of damage including abasic sites which are generated
and processed by the BER machinery [39,40].
BER enables the repair of damaged bases and requires direct recognition of the lesion by mitochondrially targeted
DNA glycosylases [41]. DNA glycosylase enzymes directly bind to and ‘flip-out’ the damaged base from the DNA
helix as well as catalysing the removal of the damaged base for further processing [42]. Several mammalian DNA gly-
cosylases recognise an array of DNA base lesions caused by either oxidation, alkylation or deamination [30]. One of
the best characterised mitochondrial examples is recognition of 8-oxoguanine by the bifunctional DNA glycosylase,
OGG1. Activity of OGG1 on the oxidised base generates a single-strand gap that can be filled by the mitochondrial
polymerase, POLγ, and sealed by DNA ligase III [43–45]. DNA glycosylases can either be monofunctional (compris-
ing solely glycosylase activity) which subsequently requires the apurinic/apyrimidinic endonuclease activity of APE1
for further processing, or bifunctional (incorporating AP lyase activity) [42]. Following processing by a monofunc-
tional DNA glycosylase, APE1 cleaves the phosphodiester bond converting the abasic site into a single-strand break
which can then be filled by POLγ [44]. In addition to POLγ, POLβ has also been shown to localise to the mitochon-
dria and is important for BER [44,46–48]. Recent research by Baptiste et al. showed that POLβ was actually more
efficient at filling single-strand DNA gaps generated through BER than POLγ [49].
Two variations of BER are possible depending on whether the DNA polymerase inserts a single nucleotide
(short-patch BER) or several nucleotides resulting in the displacement of the downstream strand creating a ‘flap’
structure (long-patch BER). The latter requires additional activity by FEN1 to remove this structure and allow liga-
tion to occur. Both short-patch and long-patch BER have been demonstrated to operate in mammalian mitochondria
[50]. Interestingly, research by Baptiste et al. also demonstrated that POLβ’s mitochondrial activity was stimulated by
TWINKLE helicase, but that this did not appear to rely on helicase activity. It would be prudent to note whether the
activity of POLβ versus POLγ in gap filling correlates with preference for either short-patch or long-patch BER. Sev-
eral additional polymerases have also been identified in mammalian mitochondria including POLθ, POLζ and the
primase polymerase, PRIMPOL [51–53]. However, their functional importance is yet to be demonstrated, though it
is possible that based on their fidelity and nuclear functions that their mitochondrial function may be skewed towards
DNA repair rather than replication.
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Figure 1. Gene ontology enrichment analysis of DNA repair proteins in the mitochondrial proteome reveals BER and DNA
recombination as enriched biological processes
(A) Protein products of genes annotated with the ‘DNA repair’ gene ontology were screened against the curated IMPI. Forty can-
didate DNA repair proteins were identified in the mitochondrial proteome representing multiple DNA repair pathways. Black circles
represent circular mtDNA in a mitochondrion (orange/pale orange). (B) GO enrichment analysis of the 40 candidate genes was
performed using clusterProfileR to identify associated biological processes [33]. Analysis reveals BER, DNA recombination, DSB
repair and DNA replication as the four most enriched biological processes.
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Figure 2. Multiple fates for damaged mtDNA
(A) The mtDNA (blue circles) encounter several base lesions including oxidation, alkylation and deamination which are primarily
repaired by BER. In contrast, DSBs are repaired either by MMEJ or trigger DNA degradation by a yet unknown mechanism. HR
repair of protein–DNA cross-links requires both homologous template sequences and RAD51 to repair damage. DSBs may also be
processed and repaired by HR. (B) During replication, abasic sites generated through BER processing are either repaired by TLS
using gap filling activity of POLγ or are targeted for degradation. Lesions present in mtDNA during replication may lead to replication
stalling and generation of further DNA breaks which can be repaired by MMEJ or potentially using the non-canonical replication
restart functions of RAD51C and XRCC3 (CX3) alongside RAD51. Purple circle represents TWINKLE helicase and Blue rectangles
represent mtSSB loading on the displaced strand, red arrow indicates direction of DNA synthesis. Red text indicates key proteins
identified in each process. Abbreviations: mtSSB, mitochondrial single-stranded binding protein; TLS, translesion synthesis.
Localisation of the BER machinery appears to be responsive to ROS generation that in turn generate oxidised bases
requiring further processing and repair by BER [54]. In support of the idea that mitochondrial nucleoids are discrete
mtDNA processing centres, DNA glycosylases alongside POLγ have been shown to be associated with these inner
membrane-associated particles [55]. In 2021, Barchiesi et al. showed that APE1 has non-canonical activities in binding
to and degrading damaged mitochondrial mRNAs containing abasic sites [56]. In support of this, the authors show
that the absence of APE1 led to the accumulation of damaged mRNA transcripts and negatively impacts oxidative
phosphorylation. Whether any other BER processing enzymes also facilitate quality control of damaged mRNAs in
mitochondria is yet to be established.
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In contrast with BER, evidence consistently suggests that nucleotide excision repair (NER) in mammalian mi-
tochondria does not occur due to an inability to remove major NER substrates such as pyrimidine dimers and in-
trastrand cross-links induced by cisplatin [57–59]. However, two types of NER exist in the nucleus, global genome
NER (GG-NER) and transcription-coupled NER (TC-NER). Despite the lack of NER proteins found in mitochondria,
the Cockayne Syndrome group B (CSB) protein, involved in TC-NER, has been shown to localise to mitochondria
although it appears that CSB in this context promotes mitochondrial BER due to the reduced BER incision activity
observed in CSB-deficient cells [60]. XPD is also an NER protein, it localises to mitochondria and appears to play a
role in repair of oxidation induced damage as mitochondria depleted of XPD fail to repair oxidised bases compared
with wildtype controls [61]. Although XPD and CSB appear to suppress accumulation of oxidative damage, their
exact role in mtDNA repair and processing of BER intermediates is yet to be established.
DSB repair in mammalian mitochondria
The ability of mammalian mitochondria to repair DSBs has remained controversial. In 2017, Moretton et al. used
an inducible mitochondrially targeted restriction enzyme to selectively induce a DSB in the mtDNA [62]. The au-
thors observed that mtDNA decreased over the period of a day suggesting that a degradation-based quality control
mechanism removed damaged mtDNA copies as a main response to DSBs. However, DSB repair by MMEJ has been
shown to occur in mitochondria and due to its error-prone nature, is thought to be at least partially responsible for
deletions that are frequently observed in mtDNA [63]. Interestingly, the authors also looked for evidence of DSB re-
pair by non-homologous end joining (NHEJ) by incubating mitochondrial extracts with blunt-ended DNA substrates
but found no evidence of this repair. Mechanistically, POLθ is known to participate in nuclear MMEJ and is one of
the additional polymerases recently shown to localise in mitochondria [51,64]. The disparate observations between
DSB repair and degradation could correlate with the extensiveness of the damage and the number of breaks present.
For example, the expression of a mitochondrially targeted restriction endonuclease may generate more breaks than
the DSB machinery can repair, at which point the balance shifts towards removal of damaged mtDNA copies rather
than repair. Additionally, DNA breaks introduced by expression of the PstI, the restriction endonuclease isolated
from Providencia stuartii, generate ‘sticky’ ends which may be more readily processed by degradation mechanisms
rather than ligation due to specificity of the repair machinery. Reciprocally, care needs to be taken to ensure that
mitochondrial extracts are devoid of contaminating proteins capable of processing recombinant DNA substrates as
well as critically appraising whether plasmid-based reporter constructs are truly representative of the mitochondrial
genome. This may prove additionally complex due to the sequestration of the mtDNA in discrete nucleoid structures
which in many cases will only contain one copy of the mtDNA per nucleoid and would otherwise lack a template for
repair [4]. Furthermore, the impact of mitochondrial DSBs appears to signal and elicit changes beyond the mitochon-
dria. Research by Tigano et al. uncovered that induction of DSBs in mitochondria using transcription activator-like
effector nucleases (TALENS) triggers a type I interferon response in the nucleus, propagated by the release of mito-
chondrial RNA into the cytoplasm [65]. Moreover, the authors show that cells lacking mtDNA failed to elicit a robust
interferon response following irradiation further indicating the fundamental role for mtDNA to nuclear signalling in
this process.
HR
In the nuclear genome, HR offers a largely error-free mechanism of DNA repair limited to the S- and G2-phases
of the cell cycle when a homologous template is available to facilitate accurate repair [66]. Due to the presence of
many copies of the mitochondrial genome, HR would in theory offer an accurate repair mechanism that could occur
independently of the cell cycle. However, the existence of HR in mitochondria has been disputed and due to the
error-free nature of repair this would not generate sequence-level changes that could easily be identified or tracked.
In the budding yeast model organism, Saccharomyces cerevisiae, recombination of mtDNA has been
well-characterised from the initial observation that recombination of genetic material could transfer genes confer-
ring drug resistance to the generation of a mitochondrial recombination hotspot map [67,68]. In mammalian cells
however, the existence of DNA recombination in mitochondria has largely been discounted, at least for germline re-
combination events due to the absence of variation of heteroplasmy over many generations in a mouse model [69].
However, evidence for the capability of mitochondria to perform HR as a means of repairing DSBs, or at least a
variation of it, is stacking up.
In the nucleus, HR requires more extensive processing of the DSB to yield a region of single-stranded DNA (ss-
DNA) via the activity of endo- and exonucleases such as MRE11, CTIP, DNA2 and EXO1 [66]. The ssDNA generated
becomes coated in replication protein A (RPA) which prevents the formation of unwanted secondary structures. RPA
6 © 2021 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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is then exchanged for the recombinase, RAD51, which forms a nucleoprotein filament on the ssDNA [66]. RAD51
drives strand exchange with a homologous template leading to the displacement of the complementary strand of the
template creating a displacement loop (D-loop) [66]. If the second broken DNA end is captured by the displaced
loop a double Holliday junction is formed [66]. DNA is then copied through DNA synthesis and branch migration
of the Holliday junctions using the complementary DNA sequence. In the final step, these structures are resolved by
the concerted activities of endonucleases which yield either a crossover or non-crossover event dependent upon the
orientation of the cuts made [70].
Evidence for HR in mammalian mitochondria originated from the use of mitochondrial extracts which are capable
of catalysing HR in a plasmid reporter system [71]. Fundamentally, this indicated that the mitochondria contain the
machinery required to process DSBs using HR. Additional studies, also using a plasmid reporter system to monitor
HR, demonstrated that certain tissue types had a greater propensity for HR including mitochondrial extracts from
the testes, brain, kidney and spleen [72]. As with nuclear HR, mitochondrial HR efficiency is attenuated by the im-
munodepletion of the RAD51, MRE11 or NIBRIN (also known as NBS-1; Nijmegen Breakage Syndrome 1) from
mitochondrial extracts prior to incubation with DNA substrates.
In mouse oocytes, loss of RAD51 leads to arrested meiosis during metaphase I accompanied by impaired ATP pro-
duction, reduced mitochondrial membrane potential and a decrease in mtDNA copy number [73]. The requirement
for RAD51 is closely linked to replication of mtDNA as RAD51 is readily localised to mitochondria following repli-
cation stress [36]. Several additional proteins required for HR are also found within the mitochondria. The RAD51
paralogues proteins structurally resemble RAD51 but are not capable of compensating for the function of each other,
thereby indicating that they each serve unique functions (reviewed by [32]). There are five canonical RAD51 par-
alogues comprising RAD51B, RAD51C, RAD51D, XRCC2 and XRCC3 which form at least two distinct complexes,
the BCDX2 complex and the CX3 complex [74]. Only two RAD51 paralogue proteins are among the mitochondrial
proteome, RAD51C and XRCC3. Sage et al. showed that depletion of either RAD51, RAD51C or XRCC3 using siR-
NAs leads to decreased mtDNA copy number instead of the compensatory increase typically observed in response to
oxidative stress [35].
Recently Chesner et al. suggests that mtDNA–protein cross-links can be repaired using HR in mammalian cells
[75]. The authors used a PCR-based assay that delivered cross-linked plasmid DNA into isolated mitochondria. They
proposed that DNA repair predominantly occurred by HR on the basis that successful repair was observed when the
plasmid contained homology to the mitochondrial genome, whereas no repair was observed in plasmids lacking ho-
mology. Furthermore, they observed that no repair occurred when RAD51 polymerisation was inhibited by the small
molecule inhibitor, B02 [76]. HR and DNA replication closely cooperate within the nucleus to permit tolerance and
bypass of DNA lesions sharing many of the same key proteins including RAD51 and the RAD51 paralogue proteins,
however mtDNA replication is functionally distinct from nuclear DNA replication [77,78].
MtDNA replication
The mitochondrial genome comprises both ‘heavy’ and ‘light’ strands referring to the nucleotide composition of the
two strands in relation to their mass [78]. Uniquely, both the heavy and light strands contain their own origins of
replication, referred to as OH and OL respectively. The OL replication origin sits approximately two-thirds of the way
round the mtDNA molecule from the OH locus. As part of the strand-displacement model, mtDNA replication ini-
tiates at OH with the aid of the mitochondrial RNA polymerase (POLRMT) which synthesises an RNA primer to
enable extended DNA synthesis by POLγ [79]. Replication then proceeds unidirectionally around the mitochondrial
genome to synthesise the new H-strand [78]. TWINKLE helicase unwinds and displaces the complementary L-strand
during this process to create a D-loop which becomes coated in the mitochondrial single-stranded binding protein
(mtSSB) [80,81]. When the helicase reaches the OL locus, displacement of the light strand results in the formation
of a stem–loop structure in this region which prevents the binding of mtSSB [82]. POLRMT is then able to initiate
synthesis of the reverse L-strand by incorporating an RNA primer that can then be used again by POLγ in the reverse
direction [83]. This synthesis continues until both strands have been fully replicated. A variation of this model re-
ferred to as RITOLS proposes that the lagging strand replication occurs concurrently with that of the leading strand
but RNA in incorporated rather than DNA (reviewed in [84]). Following DNA synthesis, RNA is then removed by
RNAse H1 and the DNA ends are ligated by DNA ligase III [84]. In the final step of mtDNA replication, the two
daughter copies must be separated. Relieving of the topological stress induced by replication is catalysed primarily by
the mitochondrial topoisomerase, TOP1MT [85].
© 2021 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Replication-associated repair
An emerging picture is developing in understanding the intricate interplay between the distinct repair pathways and
DNA replication. Processing of modified bases by the BER machinery generates abasic or ssDNA breaks depending
on the stage of processing or whether the glycosylase is mono- or bifunctional [42]. In the nucleus, if a progressing
replication fork encounters one of these intermediates, it will lead to stalling of the fork [86]. To maintain the stability
and bypass this structure, the cell can either remodel the replication fork by annealing the two nascent strands to one
another allowing synthesis of complementary sequences past the lesion followed by a strand (reviewed in [77]). This
creates a ‘chicken-foot’ structure that is stabilised by RAD51 and the BCDX2 complex [87]. To continue replicating
the DNA this structure is degraded by nucleases to yield a section of ssDNA that can strand invade ahead of the le-
sion to permit synthesis [88]. The complementary strand can then be synthesised in the reverse direction using this
new template to continue DNA replication [77]. Alternatively, a second recombination-dependent mechanism can
permit the continuation of DNA replication – this requires the controlled collapse of the replication fork to generate a
single-ended DSB [89]. The single-ended DSB is then processed to reveal a region of ssDNA that can then drive strand
invasion to restart the fork. If the DNA lesion has already been processed to generate a single-strand break this would
be converted into a DSB upon replication [90]. In which case, fork restart would potentially be favoured in response to
ssDNA BER intermediates. Interestingly, only RAD51C and XRCC3 along with RAD51 are required to perform the
latter recombination-based restart in the nucleus, with the CX3 complex having a functionally distinct role from that
of the BCDX2 complex [87,91]. Furthermore, RAD51C was recently shown to cooperate with ALKBH3 to facilitate
lesion recognition and bypass of alkylation-induced damage (N3-methylcytosine residues), which would otherwise
lead to fork stalling and genomic instability [92]. In mitochondria, RAD51, RAD51C and XRCC3 have been shown
to localise at D-loops and are enriched in mitochondrial nucleoids following replication stress caused by dideoxy-
cytidine, which stalls mitochondrial replication specifically [34]. In addition, recruitment of RAD51, RAD51C and
XRCC3 is dependent upon TWINKLE helicase indicating close cooperation of these factors with replication. In-
terestingly, POLγ enrichment on mtDNA also appears to be maintained by the presence of RAD51C and XRCC3.
Recently, Zhao et al. (2021) identified XRCC2 as a potential prognostic factor for hepatocellular carcinoma [93]. The
authors showed that XRCC2 was found in the mitochondrial fraction of cell extracts and that its depletion led to
an accumulation of mtDNA damage. This raises further questions as to whether the DNA protection function of
XRCC2 in mitochondria requires the formation of a complex or reflects the more recently discovered non-canonical
function of XRCC2 in sensing dNTP pool fluctuations [94]. Furthermore, the exact role of these proteins in mito-
chondria remains to be established, however the non-canonical roles of the proteins in the nuclear DNA replication
may potentially provide useful insights for further study.
If BER intermediates persist, the question remains as to how efficiently abasic sites are repaired within mammalian
mitochondria – this has been challenging to study as murine APE1 knockouts, that would lead to accumulation of
abasic sites, are embryonic lethal [95]. Authors overcame this limitation via generation of a haploinsufficient APE1
(+/−) transgenic mouse which displayed decreased mtDNA abundance suggesting that mtDNA containing abasic
sites was being degraded [95]. However, abasic lesions can also be bypassed by translesion synthesis (TLS) using
POLγ, though evidence suggest the efficiency of this is quite low and quickly shifts in favour of mtDNA degradation
rather than lesion bypass when the number of abasic sites increases [96].
Fanconi anaemia (FA) is a rare heritable disorder characterised by developmental defects, bone marrow failure and
an increased risk of haematological malignancies [97]. Characteristically, FA patient cells display increased genetic
instability resulting from mutations in genes governing the stability and protection of DNA replication forks from in-
terstrand cross-links [98]. These genes found to be mutated in FA are prefaced with the ‘FANC’ designation followed
by alphanumeric characters denoting the complementation group. Processing of interstrand cross-links requires the
controlled collapse of replication forks by the ‘unhooking’ of one of the strands to be replicated thereby generat-
ing a single-ended DSB [99]. This process is mediated by the FANCD2 and FANCI heterodimer which becomes
monoubiquitinated prior to recognition of the lesion [100]. Monoubiquitination of FANCD2–FANCI is facilitated by
a core complex comprising at least eight proteins [99]. Once the cross-linked base is unhooked, TLS allows synthesis
past the lesion which can then be removed by NER [99]. In the final stage of the repair process the single-ended
DSB strand invades the repaired DNA to restart the replication fork [99]. Two genes acting downstream of FA core
complex processing have already been discussed are associated with FA complementation groups, FANCRRAD51 and
FANCORAD51C [101,102]. Several additional genes with protein products required for HR are also involved in this
process including FANCD1BRCA2, FANCSBRCA1, FANCJBRIP1, FANCNPALB2 [103–106].
In support of their mitochondrial role, research has revealed that cells taken from FA patients or cells with muta-
tions in genes associated with some of the complementation groups display mitochondrial dysfunction and increased
8 © 2021 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Table 1 Evidence for mtDNA repair pathways discussed and key proteins involved in each stage of repair
DNA repair pathway Stages of repair Key mitochondrial proteins References
BER Base excision and 3′ OH generation OGG1, MUTYH, MPG, UNG1, NTH1,
NIEL1, NIEL2
[23,26,27,30,37,119–121]
DNA synthesis POLγ, POLβ [44,48]
Flap removal and ligation FEN1, LIG3 [31,45]
HR DNA end resection and strand exchange RAD51, RAD51C, XRCC2, XRCC3 [34,72,75]
Resolution ?
MMEJ Base pairing, DNA synthesis and ligation POLθ, LIG3 [63,64,114]
Replication-associated repair Fork protection MRE11, XRCC2 [93,111]
Fork restart RAD51, RAD51C, XRCC3 [34,36,111]
TLS Lesion bypass POLγ [96]
MMR Lesion recognition and replacement YB-1 [117]
generation of ROS [107,108]. More recently, FA proteins have been associated with the mitochondrial stress linked
to instability of common fragile sites and appear to be involved in mitophagy [109,110]. The exact function of these
proteins in protecting mitochondria remains largely enigmatic, however recent research by Luzwick et al. showed that
protection of mitochondrial forks required several proteins including MRE11, FANCD2, RAD51C, BRCA2 and the
endonuclease, SLX4, in response to stalling of mitochondrial replication with dideoxycytidine [111]. Interestingly,
the authors noted that neither FANCD2 monoubiquitination nor members of the FA ‘core’ complex are required for
the mitochondrial fork protection activity observed when assaying nascent mtDNA synthesis. However, some have
reported that at least FANCD2 (with or without ubiquitination) appears to be important for mitochondrial function
[109,112,113]. Critically, the involvement of some common factors, but not others to elicit a robust response suggest
interplay between existing mechanisms.
MtDNA replication is also the source of an mtDNA deletion associated with Kearns–Sayre syndrome [114]. The
‘common deletion’ which is attributed to loss of a 4977-bp segment of the mitochondrial genome is associated with
pigmentary retinopathy, cerebellar ataxia and neuromuscular defects including weakness of the eye muscles (Opthal-
moplegia) [115,116]. By developing a novel technique to temporally dual label mtDNA during replication, Phillips
et al. demonstrated that DSBs induced during replication were responsible for the deletion by attempting to re-
pair the breaks by error-prone MMEJ [114]. Furthermore, the authors approach provided strong evidence for the
strand-displacement model of mtDNA replication, as two distinct modes of labelling were observed (representing
the firing of the OH and OL independently of one another).
After mtDNA replication, DNA mismatches introduced by TLS can be corrected using mismatch repair (MMR),
which unlike nuclear MMR requires YB-1 instead of heterodimers comprising MLH and MSH proteins [117,118].
Table 1 summarises the evidence discussed for an expanded repertoire of DNA repair mechanisms in mammalian
mitochondria alongside highlighting key proteins involved in each stage of repair. Critically, the full complement of
factors required to elicit most of these repair process in mitochondria have yet to be identified. Ultimately further
research will be required to tease out these specific mechanisms and determine their similarity or difference with
existing mechanisms characterised in the repair of nuclear DNA damage.
Summary
In summary, significant strides have been made to identify and characterise the mechanisms that protect the integrity
of the mitochondrial genome. This expanded portfolio of mechanisms comprising at least BER, MMEJ, TLS, MMR
with emerging evidence for HR and HR mediated restart of stalled mitochondrial replication [41,42,63,96,117]. Crit-
ically, this suggests that mammalian mitochondria are better equipped than previously thought to tolerate and repair
the high levels of damaging agents they are exposed to through cellular respiration [37]. Despite many known nu-
clear DNA repair proteins being shown to localise in mitochondria, the functional importance of these proteins in
the context of DNA repair remains enigmatic. Nuclear functions of these proteins have provided important insights
into their likely mitochondrial role; however, the development of novel assays to assess mtDNA repair and replication
may yield important insights in future to help characterise these mechanisms. Critically, unlike the well-characterised
mitochondrial BER pathway, other repair mechanisms do not necessarily have a full complement of proteins to enable
mtDNA repair to occur like-for-like with the nuclear DNA. As a result, it remains a possibility that combinations of
repair pathways offer mechanisms to tolerate DNA lesions, which potentially may be coupled with mtDNA replica-
tion to permit a diverse response to differing DNA lesions. Indeed, further identification of non-canonical roles of
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mitochondrially localised proteins may also offer important insights, whether closely aligned to DNA repair and repli-
cation or unique functions such as recognition and degradation of damaged mRNAs [56]. Proving the existence and
feasibility of repair using these mechanisms relies on accurate evaluation and validation of the cellular compartmen-
talisation of these proteins. Proteomic evidence has provided a significant snapshot into mitochondrial localisation,
however greater questions remain in establishing how mitochondrial localisation is achieved, particularly when mi-
tochondrial localisation appears responsive to damage [54]. Challenges also remain on whether localisation can truly
accurately be predicted on genetic, transcript or peptide sequences alone or whether the protein–protein interac-
tome can also play a significant role. Lastly, discovery of the mechanism governing the degradation of mtDNA will
be critical to understanding the potential interplay and balancing act between repair and degradation [62].
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